Due to the sex hormone dependence of this benign tumor, hormonal therapy with gonadotropin-releasing hormone agonists, progesterone antagonists, selective estrogen receptor modulators, and aromatase inhibitors has been considered effective, and some studies have reported success with hormonal therapy [15]. Here, CYP19A1 is linked to benign neoplasm.